<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="sectionType"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>This code system https://www.hl7.org/fhir/us-pq-cmc/CodeSystem/sectionType defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">32S10<a name="sectionType-32S10"> </a></td><td>Substance General Information</td></tr><tr><td style="white-space:nowrap">32S11<a name="sectionType-32S11"> </a></td><td>Substance Nomenclature</td></tr><tr><td style="white-space:nowrap">32S12<a name="sectionType-32S12"> </a></td><td>Substance Structure</td></tr><tr><td style="white-space:nowrap">32S13<a name="sectionType-32S13"> </a></td><td>Substance General Properties</td></tr><tr><td style="white-space:nowrap">32S20<a name="sectionType-32S20"> </a></td><td>Substance Manufacture</td></tr><tr><td style="white-space:nowrap">32S21<a name="sectionType-32S21"> </a></td><td>Substance Manufacturers</td></tr><tr><td style="white-space:nowrap">32S22<a name="sectionType-32S22"> </a></td><td>Substance Description of Manufacturing Process and Process Controls</td></tr><tr><td style="white-space:nowrap">32S23<a name="sectionType-32S23"> </a></td><td>Substance Control of Materials</td></tr><tr><td style="white-space:nowrap">32S24<a name="sectionType-32S24"> </a></td><td>Substance Controls of Critical Steps and Intermediates</td></tr><tr><td style="white-space:nowrap">32S25<a name="sectionType-32S25"> </a></td><td>Substance Process Validation and/or Evaluation</td></tr><tr><td style="white-space:nowrap">32S26<a name="sectionType-32S26"> </a></td><td>Substance Manufacturing Process Development</td></tr><tr><td style="white-space:nowrap">32S30<a name="sectionType-32S30"> </a></td><td>Substance Characterization</td></tr><tr><td style="white-space:nowrap">32S31<a name="sectionType-32S31"> </a></td><td>Substance Elucidation of Structure and other Characteristics</td></tr><tr><td style="white-space:nowrap">32S32<a name="sectionType-32S32"> </a></td><td>Substance Impurities</td></tr><tr><td style="white-space:nowrap">32S40<a name="sectionType-32S40"> </a></td><td>Substance Control of Drug Substance</td></tr><tr><td style="white-space:nowrap">32S41<a name="sectionType-32S41"> </a></td><td>Substance Specification</td></tr><tr><td style="white-space:nowrap">32S42<a name="sectionType-32S42"> </a></td><td>Substance Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32S43<a name="sectionType-32S43"> </a></td><td>Substance Validation of Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32S44<a name="sectionType-32S44"> </a></td><td>Substance Batch Analyses</td></tr><tr><td style="white-space:nowrap">32S45<a name="sectionType-32S45"> </a></td><td>Substance Justification of Specification</td></tr><tr><td style="white-space:nowrap">32S50<a name="sectionType-32S50"> </a></td><td>Substance Reference Standards or Materials</td></tr><tr><td style="white-space:nowrap">32S60<a name="sectionType-32S60"> </a></td><td>Substance Container Closure System</td></tr><tr><td style="white-space:nowrap">32S70<a name="sectionType-32S70"> </a></td><td>Substance Stability</td></tr><tr><td style="white-space:nowrap">32S71<a name="sectionType-32S71"> </a></td><td>Substance Stability Summary and Conclusions</td></tr><tr><td style="white-space:nowrap">32S72<a name="sectionType-32S72"> </a></td><td>Substance Postapproval Stability Protocol and Stability Commitment</td></tr><tr><td style="white-space:nowrap">32S73<a name="sectionType-32S73"> </a></td><td>Substance Stability Data</td></tr><tr><td style="white-space:nowrap">32P10<a name="sectionType-32P10"> </a></td><td>Product Description and Composition of the Drug Product</td></tr><tr><td style="white-space:nowrap">32P20<a name="sectionType-32P20"> </a></td><td>Product Pharmaceutical Development</td></tr><tr><td style="white-space:nowrap">32P21<a name="sectionType-32P21"> </a></td><td>Product Components of the Drug Product</td></tr><tr><td style="white-space:nowrap">32P22<a name="sectionType-32P22"> </a></td><td>Product Drug Product</td></tr><tr><td style="white-space:nowrap">32P23<a name="sectionType-32P23"> </a></td><td>Product Manufacturing Process Development</td></tr><tr><td style="white-space:nowrap">32P24<a name="sectionType-32P24"> </a></td><td>Product Container Closure System</td></tr><tr><td style="white-space:nowrap">32P25<a name="sectionType-32P25"> </a></td><td>Product Microbiological Attributes</td></tr><tr><td style="white-space:nowrap">32P26<a name="sectionType-32P26"> </a></td><td>Product Compatibility</td></tr><tr><td style="white-space:nowrap">32P30<a name="sectionType-32P30"> </a></td><td>Product Manufacture</td></tr><tr><td style="white-space:nowrap">32P31<a name="sectionType-32P31"> </a></td><td>Product Manufacturers</td></tr><tr><td style="white-space:nowrap">32P32<a name="sectionType-32P32"> </a></td><td>Product Batch Formula</td></tr><tr><td style="white-space:nowrap">32P33<a name="sectionType-32P33"> </a></td><td>Product Description of Manufacturing Process and Process Controls</td></tr><tr><td style="white-space:nowrap">32P34<a name="sectionType-32P34"> </a></td><td>Product Controls of Critical Steps and Intermediates</td></tr><tr><td style="white-space:nowrap">32P35<a name="sectionType-32P35"> </a></td><td>Product Process Validation and/or Evaluation</td></tr><tr><td style="white-space:nowrap">32P40<a name="sectionType-32P40"> </a></td><td>Product Control of Excipients</td></tr><tr><td style="white-space:nowrap">32P41<a name="sectionType-32P41"> </a></td><td>Excipients Specifications</td></tr><tr><td style="white-space:nowrap">32P42<a name="sectionType-32P42"> </a></td><td>Product Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P43<a name="sectionType-32P43"> </a></td><td>Product Validation of Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P44<a name="sectionType-32P44"> </a></td><td>Product Justification of Specifications</td></tr><tr><td style="white-space:nowrap">32P45<a name="sectionType-32P45"> </a></td><td>Product Excipients of Human or Animal Origin</td></tr><tr><td style="white-space:nowrap">32P46<a name="sectionType-32P46"> </a></td><td>Product Novel Excipients</td></tr><tr><td style="white-space:nowrap">32P50<a name="sectionType-32P50"> </a></td><td>Product name - dosage form</td></tr><tr><td style="white-space:nowrap">32P51<a name="sectionType-32P51"> </a></td><td>Product Specifications</td></tr><tr><td style="white-space:nowrap">32P52<a name="sectionType-32P52"> </a></td><td>Product Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P53<a name="sectionType-32P53"> </a></td><td>Product Validation of Analytical Procedures</td></tr><tr><td style="white-space:nowrap">32P54<a name="sectionType-32P54"> </a></td><td>Product Batch Analyses</td></tr><tr><td style="white-space:nowrap">32P55<a name="sectionType-32P55"> </a></td><td>Product Characterization of Impurities</td></tr><tr><td style="white-space:nowrap">32P56<a name="sectionType-32P56"> </a></td><td>Product Justification of Specifications</td></tr><tr><td style="white-space:nowrap">32P60<a name="sectionType-32P60"> </a></td><td>Product Reference Standards or Materials</td></tr><tr><td style="white-space:nowrap">32P70<a name="sectionType-32P70"> </a></td><td>Product Container Closure System</td></tr><tr><td style="white-space:nowrap">32P80<a name="sectionType-32P80"> </a></td><td>Product Stability</td></tr><tr><td style="white-space:nowrap">32P81<a name="sectionType-32P81"> </a></td><td>Product Stability Summary and Conclusion</td></tr><tr><td style="white-space:nowrap">32P82<a name="sectionType-32P82"> </a></td><td>Product Postapproval Stability Protocol and Stability Commitment</td></tr><tr><td style="white-space:nowrap">32P83<a name="sectionType-32P83"> </a></td><td>Product Stability Data</td></tr><tr><td style="white-space:nowrap">SP4151<a name="sectionType-SP4151"> </a></td><td>Quality Specification</td></tr></table></div>
  </text>
  <url value="https://www.hl7.org/fhir/us-pq-cmc/CodeSystem/sectionType"/>
  <version value="current"/>
  <name value="CompSectionTypes"/>
  <title value="Composition Section Type"/>
  <status value="draft"/>
  <date value="2020-04-06T10:07:08-04:00"/>
  <publisher value="U.S. Federal Drug Administration"/>
  <description value="Classification of a sections of a PQ/CMC composition/document generally based on eCTD Module 3 section numbering for product and substance. A composition can have many section codes."/>
  <content value="complete"/>
  <count value="61"/>
  <concept>
    <code value="32S10"/>
    <display value="Substance General Information"/>
  </concept>
  <concept>
    <code value="32S11"/>
    <display value="Substance Nomenclature"/>
  </concept>
  <concept>
    <code value="32S12"/>
    <display value="Substance Structure"/>
  </concept>
  <concept>
    <code value="32S13"/>
    <display value="Substance General Properties"/>
  </concept>
  <concept>
    <code value="32S20"/>
    <display value="Substance Manufacture"/>
  </concept>
  <concept>
    <code value="32S21"/>
    <display value="Substance Manufacturers"/>
  </concept>
  <concept>
    <code value="32S22"/>
    <display value="Substance Description of Manufacturing Process and Process Controls"/>
  </concept>
  <concept>
    <code value="32S23"/>
    <display value="Substance Control of Materials"/>
  </concept>
  <concept>
    <code value="32S24"/>
    <display value="Substance Controls of Critical Steps and Intermediates"/>
  </concept>
  <concept>
    <code value="32S25"/>
    <display value="Substance Process Validation and/or Evaluation"/>
  </concept>
  <concept>
    <code value="32S26"/>
    <display value="Substance Manufacturing Process Development"/>
  </concept>
  <concept>
    <code value="32S30"/>
    <display value="Substance Characterization"/>
  </concept>
  <concept>
    <code value="32S31"/>
    <display value="Substance Elucidation of Structure and other Characteristics"/>
  </concept>
  <concept>
    <code value="32S32"/>
    <display value="Substance Impurities"/>
  </concept>
  <concept>
    <code value="32S40"/>
    <display value="Substance Control of Drug Substance"/>
  </concept>
  <concept>
    <code value="32S41"/>
    <display value="Substance Specification"/>
  </concept>
  <concept>
    <code value="32S42"/>
    <display value="Substance Analytical Procedures"/>
  </concept>
  <concept>
    <code value="32S43"/>
    <display value="Substance Validation of Analytical Procedures"/>
  </concept>
  <concept>
    <code value="32S44"/>
    <display value="Substance Batch Analyses"/>
  </concept>
  <concept>
    <code value="32S45"/>
    <display value="Substance Justification of Specification"/>
  </concept>
  <concept>
    <code value="32S50"/>
    <display value="Substance Reference Standards or Materials"/>
  </concept>
  <concept>
    <code value="32S60"/>
    <display value="Substance Container Closure System"/>
  </concept>
  <concept>
    <code value="32S70"/>
    <display value="Substance Stability"/>
  </concept>
  <concept>
    <code value="32S71"/>
    <display value="Substance Stability Summary and Conclusions"/>
  </concept>
  <concept>
    <code value="32S72"/>
    <display value="Substance Postapproval Stability Protocol and Stability Commitment"/>
  </concept>
  <concept>
    <code value="32S73"/>
    <display value="Substance Stability Data"/>
  </concept>
  <concept>
    <code value="32P10"/>
    <display value="Product Description and Composition of the Drug Product"/>
  </concept>
  <concept>
    <code value="32P20"/>
    <display value="Product Pharmaceutical Development"/>
  </concept>
  <concept>
    <code value="32P21"/>
    <display value="Product Components of the Drug Product"/>
  </concept>
  <concept>
    <code value="32P22"/>
    <display value="Product Drug Product"/>
  </concept>
  <concept>
    <code value="32P23"/>
    <display value="Product Manufacturing Process Development"/>
  </concept>
  <concept>
    <code value="32P24"/>
    <display value="Product Container Closure System"/>
  </concept>
  <concept>
    <code value="32P25"/>
    <display value="Product Microbiological Attributes"/>
  </concept>
  <concept>
    <code value="32P26"/>
    <display value="Product Compatibility"/>
  </concept>
  <concept>
    <code value="32P30"/>
    <display value="Product Manufacture"/>
  </concept>
  <concept>
    <code value="32P31"/>
    <display value="Product Manufacturers"/>
  </concept>
  <concept>
    <code value="32P32"/>
    <display value="Product Batch Formula"/>
  </concept>
  <concept>
    <code value="32P33"/>
    <display value="Product Description of Manufacturing Process and Process Controls"/>
  </concept>
  <concept>
    <code value="32P34"/>
    <display value="Product Controls of Critical Steps and Intermediates"/>
  </concept>
  <concept>
    <code value="32P35"/>
    <display value="Product Process Validation and/or Evaluation"/>
  </concept>
  <concept>
    <code value="32P40"/>
    <display value="Product Control of Excipients"/>
  </concept>
  <concept>
    <code value="32P41"/>
    <display value="Excipients Specifications"/>
  </concept>
  <concept>
    <code value="32P42"/>
    <display value="Product Analytical Procedures"/>
  </concept>
  <concept>
    <code value="32P43"/>
    <display value="Product Validation of Analytical Procedures"/>
  </concept>
  <concept>
    <code value="32P44"/>
    <display value="Product Justification of Specifications"/>
  </concept>
  <concept>
    <code value="32P45"/>
    <display value="Product Excipients of Human or Animal Origin"/>
  </concept>
  <concept>
    <code value="32P46"/>
    <display value="Product Novel Excipients"/>
  </concept>
  <concept>
    <code value="32P50"/>
    <display value="Product name - dosage form"/>
  </concept>
  <concept>
    <code value="32P51"/>
    <display value="Product Specifications"/>
  </concept>
  <concept>
    <code value="32P52"/>
    <display value="Product Analytical Procedures"/>
  </concept>
  <concept>
    <code value="32P53"/>
    <display value="Product Validation of Analytical Procedures"/>
  </concept>
  <concept>
    <code value="32P54"/>
    <display value="Product Batch Analyses"/>
  </concept>
  <concept>
    <code value="32P55"/>
    <display value="Product Characterization of Impurities"/>
  </concept>
  <concept>
    <code value="32P56"/>
    <display value="Product Justification of Specifications"/>
  </concept>
  <concept>
    <code value="32P60"/>
    <display value="Product Reference Standards or Materials"/>
  </concept>
  <concept>
    <code value="32P70"/>
    <display value="Product Container Closure System"/>
  </concept>
  <concept>
    <code value="32P80"/>
    <display value="Product Stability"/>
  </concept>
  <concept>
    <code value="32P81"/>
    <display value="Product Stability Summary and Conclusion"/>
  </concept>
  <concept>
    <code value="32P82"/>
    <display value="Product Postapproval Stability Protocol and Stability Commitment"/>
  </concept>
  <concept>
    <code value="32P83"/>
    <display value="Product Stability Data"/>
  </concept>
  <concept>
    <code value="SP4151"/>
    <display value="Quality Specification"/>
  </concept>
</CodeSystem>